A growing number of men are choosing brachytherapy over radiation treatments or surgery. Brachytherapy, which consists of radioactive pellets, or "seeds," inserted into the gland where they destroy cancerous cells, has grown as the treatment of choice from 2% of men with prostate cancer in 1992 to 36% in 1999.

Related Summaries